Published in Transplantation on June 15, 2008
Biliary complications after liver transplantation from donation after cardiac death donors: an analysis of risk factors and long-term outcomes from a single center. Ann Surg (2011) 1.98
Transplantation of kidneys from donors at increased risk for blood-borne viral infection: recipient outcomes and patterns of organ use. Am J Transplant (2009) 0.94
Minimising cold ischaemic time is essential in cardiac death donor-associated liver transplantation. HPB (Oxford) (2011) 0.84
Outcomes of transplantation of livers from donation after circulatory death donors in the UK: a cohort study. BMJ Open (2013) 0.83
Aetiology and risk factors of ischaemic cholangiopathy after liver transplantation. World J Gastroenterol (2014) 0.80
Simultaneous liver and kidney transplantation using donation after cardiac death donors: a brief report. Liver Transpl (2011) 0.75
Kidney donation after cardiac death. World J Nephrol (2012) 0.75
Donor preoperative oxygen delivery and post-extubation hypoxia impact donation after circulatory death hypoxic cholangiopathy. World J Gastroenterol (2016) 0.75
Functional Implications of Biochemical and Molecular Characteristics of Donation After Circulatory Death Livers. Transplant Direct (2015) 0.75
HLA-mismatched renal transplantation without maintenance immunosuppression. N Engl J Med (2008) 7.42
The survival benefit of liver transplantation. Am J Transplant (2005) 5.08
Effect of dipyridamole plus aspirin on hemodialysis graft patency. N Engl J Med (2009) 3.69
Blockade of CTLA-4 on CD4+CD25+ regulatory T cells abrogates their function in vivo. J Immunol (2006) 3.42
New OPTN/UNOS policy for liver transplant allocation: standardization of liver imaging, diagnosis, classification, and reporting of hepatocellular carcinoma. Radiology (2013) 2.76
Statins are independently associated with reduced mortality in patients undergoing infrainguinal bypass graft surgery for critical limb ischemia. J Vasc Surg (2008) 2.55
A report of the Vancouver Forum on the care of the live organ donor: lung, liver, pancreas, and intestine data and medical guidelines. Transplantation (2006) 2.55
Donor kidney exchanges. Am J Transplant (2004) 2.39
Identification of a microRNA signature of renal ischemia reperfusion injury. Proc Natl Acad Sci U S A (2010) 2.31
Gender disparities in the live kidney donor evaluation process. Transplantation (2006) 2.10
Impact of center volume on outcomes of increased-risk liver transplants. Liver Transpl (2011) 2.10
Obesity and its impact on transplantation and alloimmunity. Transplantation (2013) 2.07
Rationing lung transplants--procedural fairness in allocation and appeals. N Engl J Med (2013) 2.05
Three patients with full facial transplantation. N Engl J Med (2011) 2.05
Incidence of death and potentially life-threatening near-miss events in living donor hepatic lobectomy: a world-wide survey. Liver Transpl (2013) 2.00
Practices and barriers in long-term living kidney donor follow-up: a survey of U.S. transplant centers. Transplantation (2009) 1.98
Maintenance immunosuppression with target-of-rapamycin inhibitors is associated with a reduced incidence of de novo malignancies. Transplantation (2005) 1.94
Association of the type of induction immunosuppression with posttransplant lymphoproliferative disorder, graft survival, and patient survival after primary kidney transplantation. Transplantation (2003) 1.88
Report of the Paris consensus meeting on expanded criteria donors in liver transplantation. Liver Transpl (2008) 1.75
Failure of fibrotic liver regeneration in mice is linked to a severe fibrogenic response driven by hepatic progenitor cell activation. Am J Pathol (2013) 1.73
Admission volume determines outcome for patients with acute pancreatitis. Gastroenterology (2009) 1.73
Surgical management of acute cholecystitis at a tertiary care center in the modern era. Arch Surg (2010) 1.70
Expanded criteria donor grafts for deceased donor liver transplantation under the MELD system: a decision analysis. Liver Transpl (2004) 1.69
Organ procurement and perfusion before transplantation. N Engl J Med (2009) 1.66
ABO-incompatible liver transplantation with no immunological graft losses using total plasma exchange, splenectomy, and quadruple immunosuppression: evidence for accommodation. Liver Transpl (2003) 1.65
Comparing living donor and deceased donor liver transplantation: A matched national analysis from 2007 to 2012. Liver Transpl (2014) 1.63
Liver transplantation for hepatocellular cancer: the impact of the MELD allocation policy. Gastroenterology (2004) 1.61
MELD score as a predictor of pretransplant and posttransplant survival in OPTN/UNOS status 1 patients. Hepatology (2004) 1.57
Survival after liver transplantation using hepatitis C virus-positive donor allografts: case-controlled analysis of the UNOS database. World J Surg (2011) 1.57
Predicting the probability of progression-free survival in patients with small hepatocellular carcinoma. Liver Transpl (2002) 1.57
Four cases of cardiopulmonary thromboembolism during liver transplantation without the use of antifibrinolytic drugs. Anesth Analg (2005) 1.56
The dispersal of mucosal memory B cells: evidence from persistent EBV infection. Immunity (2002) 1.56
Reproduction and transplantation: report on the AST Consensus Conference on Reproductive Issues and Transplantation. Am J Transplant (2005) 1.52
Colectomy performance improvement within NSQIP 2005-2008. J Surg Res (2011) 1.50
Complications after pancreatectomy for neuroendocrine tumors: a national study. J Surg Res (2010) 1.49
Liver regeneration and surgical outcome in donors of right-lobe liver grafts. Transplantation (2003) 1.49
Hospital volume as a surrogate for laparoscopically assisted colectomy. Surg Endosc (2009) 1.48
Aspirin-triggered lipoxin and resolvin E1 modulate vascular smooth muscle phenotype and correlate with peripheral atherosclerosis. Am J Pathol (2010) 1.47
In pursuit of the ideal liver allocation model. Liver Transpl (2002) 1.45
Post-transplant de novo malignancies in renal transplant recipients: the past and present. Transpl Int (2006) 1.45
Report of the Crystal City meeting to maximize the use of organs recovered from the cadaver donor. Am J Transplant (2002) 1.44
Periodontitis and inflammatory markers in transplant recipients. J Periodontol (2010) 1.42
Reimbursement for living kidney donor follow-up care: how often does donor insurance pay? Transplantation (2012) 1.39
Outcomes with conversion from calcineurin inhibitors to sirolimus after renal transplantation in the context of steroid withdrawal or steroid continuation. Transplantation (2009) 1.39
Predictors of failure after pancreaticoduodenectomy for ampullary carcinoma. J Am Coll Surg (2005) 1.39
Penis Transplantation: First US Experience. Ann Surg (2017) 1.38
Surgeon volume impacts hospital mortality for pancreatic resection. Ann Surg (2009) 1.34
Design of the Dialysis Access Consortium (DAC) Clopidogrel Prevention of Early AV Fistula Thrombosis Trial. Clin Trials (2005) 1.31
Regional variations in peer reviewed liver allocation under the MELD system. Am J Transplant (2005) 1.31
Cutting edge: transplantation tolerance through enhanced CTLA-4 expression. J Immunol (2003) 1.30
Restoration of liver mass after injury requires proliferative and not embryonic transcriptional patterns. J Biol Chem (2007) 1.27
Enzyme-linked immunosorbent spot assay for donor-reactive interferon-gamma-producing cells identifies T-cell presensitization and correlates with graft function at 6 and 12 months in renal-transplant recipients. Transplantation (2004) 1.25
Age and immune response in organ transplantation. Transplantation (2005) 1.23
Decrease in hepatic CD56(+) T cells and V alpha 24(+) natural killer T cells in chronic hepatitis C viral infection. J Hepatol (2002) 1.22
The expanded criteria donor dilemma in cadaveric renal transplantation. Transplantation (2003) 1.22
National complication rates after pancreatectomy: beyond mere mortality. J Gastrointest Surg (2009) 1.22
A prospective, randomized, clinical trial of intraoperative versus postoperative Thymoglobulin in adult cadaveric renal transplant recipients. Transplantation (2003) 1.19
Procalcitonin versus C-reactive protein and immature-to-total neutrophil ratio as markers of infection after cardiopulmonary bypass in children. Pediatr Crit Care Med (2009) 1.19
Summary report of a national conference: Evolving concepts in liver allocation in the MELD and PELD era. December 8, 2003, Washington, DC, USA. Liver Transpl (2004) 1.19
Living donor liver transplantation in adults: vascular variants important in surgical planning for donors and recipients. AJR Am J Roentgenol (2003) 1.17
Nationwide volume and mortality after elective surgery in cirrhotic patients. J Am Coll Surg (2008) 1.16
Cytokine gene promoter polymorphisms and mortality in acute renal failure. Cytokine (2004) 1.15
Increased biliary fistulas after liver resection with the harmonic scalpel. Am Surg (2003) 1.13
Carbon monoxide expedites metabolic exhaustion to inhibit tumor growth. Cancer Res (2013) 1.12
Spouse caregivers of kidney transplant patients: quality of life and psychosocial outcomes. Prog Transplant (2010) 1.12
Aggressive venous neointimal hyperplasia in a pig model of arteriovenous graft stenosis. Kidney Int (2002) 1.12
Surgical specialization and operative mortality in hepato-pancreatico-biliary (HPB) surgery. J Gastrointest Surg (2008) 1.11
Surgeon volume metrics in laparoscopic cholecystectomy. Dig Dis Sci (2009) 1.11
Living donor liver transplantation for hepatocellular carcinoma: Increased recurrence but improved survival. Liver Transpl (2009) 1.10
Racial differences in cancer specialist consultation, treatment, and outcomes for locoregional pancreatic adenocarcinoma. Ann Surg Oncol (2009) 1.10
Trends in surgical management for acute cholecystitis. Surgery (2008) 1.09
New serum markers of hepatocellular carcinoma. Semin Oncol (2012) 1.09
Living donor adult liver transplantation: a longitudinal study of the donor's quality of life. Am J Transplant (2005) 1.09
Conformational analysis of NMDA receptor GluN1, GluN2, and GluN3 ligand-binding domains reveals subtype-specific characteristics. Structure (2013) 1.09
Point-of-care prognosis for common musculoskeletal pain in older adults. JAMA Intern Med (2013) 1.08
Predictors of major complications after laparoscopic cholecystectomy: surgeon, hospital, or patient? J Am Coll Surg (2010) 1.07
The "House Calls" trial: a randomized controlled trial to reduce racial disparities in live donor kidney transplantation: rationale and design. Contemp Clin Trials (2012) 1.07
Model for end-stage liver disease (MELD) exception guidelines. Liver Transpl (2006) 1.07
Establishment of a global virtual laboratory for transplantation: a symposium report. Transplantation (2015) 1.07
On the intraoperative molecular status of renal allografts after vascular reperfusion and clinical outcomes. J Am Soc Nephrol (2005) 1.07
Technical factors affecting autogenous vein graft failure: observations from a large multicenter trial. J Vasc Surg (2007) 1.07
Symptomatic lymphoceles after kidney transplantation - multivariate analysis of risk factors and outcome after laparoscopic fenestration. Clin Transplant (2009) 1.06
CMV hepatitis after liver transplantation: incidence, clinical course, and long-term follow-up. Liver Transpl (2002) 1.05
Does increasing insurance improve outcomes for US cancer patients? J Surg Res (2013) 1.05
Clinical characteristics, treatment, and outcome of pancreatic Schwannomas. J Gastrointest Surg (2004) 1.05
Chronic rejection: the next major challenge for pancreas transplant recipients. Transplantation (2003) 1.05